technology+therapeutics

U.S. cases of COVID-19 have surged to a seven-day average of more than 150,000 per day, up from less than 10,000 in June, according to federal data, as the contagious new Delta variant continues to circulate.

Drug-resistant bloodstream infections at hospitals rose 47 percent in the last three months of 2020 compared to the same period a year earlier.

Worldwide, some people died of the delta variant despite being fully vaccinated. Is the COVID-19 vaccination no longer sufficient?

A major review of vaccines suggests the AstraZeneca jab does raise the risk of blood clots and another serious condition that can cause bleeding.

ZIN, the Dutch health technology appraisal institute, has slammed the pricing of another rare disease treatment.

An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech COVID-19 vaccine for people over age 16.

Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug meant for horses.

More information on the latest COVID-19 variants and mutations.

The race between covid-19 vaccines and variants is on.

Industrialized nations have already donated tens of millions of vaccine doses via the UN's COVAX vaccine program. But it's a slow process.

The drug would cost roughly $300,000 per patient annually in France, excluding discounts, and Biomarin said it expects the list price in Germany to be consistent with that in France.

What's the deal with Covid variants? How well do the different Covid vaccines protect against the several variants?

CDC Director Dr. Rochelle Welensky warned that the effectiveness of the COVID-19 vaccine has decreased.

This year the World Preview focuses on how biopharma companies are navigating this new landscape, and the potential lasting effects of the pandemic.

The data, published in the U.S. Centers for Disease Control and Prevention's weekly report on death and disease, shows an increase in so-called "breakthrough" infections among fully vaccinated individuals.